Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
M Castanheira, PJ Simner… - JAC-antimicrobial …, 2021 - academic.oup.com
Extended-spectrum β-lactamase (ESBL)-producing Gram-negative pathogens are a major
cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the …
cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the …
Epidemiology of β-lactamase-producing pathogens
K Bush, PA Bradford - Clinical microbiology reviews, 2020 - Am Soc Microbiol
SUMMARY β-Lactam antibiotics have been widely used as therapeutic agents for the past
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program
Bloodstream infection (BSI) organisms were consecutively collected from> 200 medical
centers in 45 nations between 1997 and 2016. Species identification and susceptibility …
centers in 45 nations between 1997 and 2016. Species identification and susceptibility …
“One Health” perspective on prevalence of co-existing extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: a …
Abstract Background The Escherichia coli (E. coli) and Klebsiella pneumoniae (K.
pneumoniae) bacterial isolates that produce extended-spectrum β-lactamases (ESBLs) …
pneumoniae) bacterial isolates that produce extended-spectrum β-lactamases (ESBLs) …
Antimicrobial use in US hospitals: comparison of results from emerging infections program prevalence surveys, 2015 and 2011
SS Magill, E O'Leary, SM Ray, MA Kainer… - Clinical infectious …, 2021 - academic.oup.com
Background In the 2011 US hospital prevalence survey of healthcare-associated infections
and antimicrobial use 50% of patients received antimicrobial medications on the survey date …
and antimicrobial use 50% of patients received antimicrobial medications on the survey date …
Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Infections—A Retrospective Study of Symptomatic Urinary …
Background Community-acquired extended-spectrum beta-lactamase–producing
Enterobacteriaceae (ESBL) infections are an evolving public health problem. Identifying …
Enterobacteriaceae (ESBL) infections are an evolving public health problem. Identifying …
Multidrug resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and to the perspectives of antimicrobial …
Antibiotic poly-resistance (multidrug-, extreme-, and pan-drug resistance) is controlled by
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …
Is piperacillin-tazobactam effective for the treatment of pyelonephritis caused by extended-spectrum β-lactamase–producing organisms?
Background Limited data exist regarding the efficacy of piperacillin-tazobactam (TZP) for the
management of nonbacteremic pyelonephritis caused by extended-spectrum β-lactamase …
management of nonbacteremic pyelonephritis caused by extended-spectrum β-lactamase …
Extended-Spectrum Beta-Lactamases Producing Enterobacteriaceae in the USA Dairy Cattle Farms and Implications for Public Health
BD Gelalcha, O Kerro Dego - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance (AMR) is one of the top global health threats of the 21th century.
Recent studies are increasingly reporting the rise in extended-spectrum beta-lactamases …
Recent studies are increasingly reporting the rise in extended-spectrum beta-lactamases …
A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective
Background: Healthcare-associated infection (HCAI) is a global health challenge, not only
as an issue of patient safety but also as a major driver of antimicrobial resistance (AMR). It is …
as an issue of patient safety but also as a major driver of antimicrobial resistance (AMR). It is …